﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 21 May 2026 04:22:22 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>Região do Sul da Ordem dos Médicos - OMSUL - Vacinação</title><link>https://http%3a%2f%2fwww.omsul.pt</link><atom:link href="https://www.omsul.pt:443/noticias/rss/category/549/vacinação" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update]]></title><link>https://www.omsul.pt/noticias/ecdc-rapid-risk-assessment-assessing-sars-cov-2-circulation-variants-of-concern-non-pharmaceutical-interventions-and-vaccine-rollout-in-the-eueea-15th-update</link><description><![CDATA[ https://www.ecdc.europa.eu/ sites/default/files/documents/ RRA-15th-update-June%202021. pdf  ]]></description><pubDate>Mon, 26 Jul 2021 09:30:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-rapid-risk-assessment-assessing-sars-cov-2-circulation-variants-of-concern-non-pharmaceutical-interventions-and-vaccine-rollout-in-the-eueea-15th-update</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16893]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Countering online vaccine misinformation in the EU/EEA]]></title><link>https://www.omsul.pt/noticias/ecdc-countering-online-vaccine-misinformation-in-the-eueea</link><description><![CDATA[ https://www.ecdc.europa.eu/ sites/default/files/documents/ Countering-online-vaccine- misinformation-in-the-EU-EEA. pdf     ]]></description><pubDate>Mon, 26 Jul 2021 09:28:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-countering-online-vaccine-misinformation-in-the-eueea</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16892]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[JAMA - SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women]]></title><link>https://www.omsul.pt/noticias/jama-sars-cov-2-specific-antibodies-in-breast-milk-after-covid-19-vaccination-of-breastfeeding-women</link><description><![CDATA[ https://jamanetwork.com/ journals/jama/fullarticle/ 2778766     ]]></description><pubDate>Mon, 26 Jul 2021 09:26:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/jama-sars-cov-2-specific-antibodies-in-breast-milk-after-covid-19-vaccination-of-breastfeeding-women</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16891]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[NEJM - Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant]]></title><link>https://www.omsul.pt/noticias/nejm-effectiveness-of-covid-19-vaccines-against-the-b16172-delta-variant</link><description><![CDATA[ https://www.nejm.org/doi/ full/10.1056/NEJMoa2108891? query=TOC&cid=NEJM%20eToc,% 20July%2022,%202021%20B% 20DM162200_NEJM_Non_ Subscriber&bid=561013160     ]]></description><pubDate>Mon, 26 Jul 2021 09:24:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/nejm-effectiveness-of-covid-19-vaccines-against-the-b16172-delta-variant</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16890]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[BMJ - Covid-19 vaccines for children: hypothetical benefits to adults do not outweigh risks to children]]></title><link>https://www.omsul.pt/noticias/bmj-covid-19-vaccines-for-children-hypothetical-benefits-to-adults-do-not-outweigh-risks-to-children</link><description><![CDATA[ https://blogs.bmj.com/bmj/ 2021/07/13/covid-19-vaccines- for-children-hypothetical- benefits-to-adults-do-not- outweigh-risks-to-children/     ]]></description><pubDate>Mon, 26 Jul 2021 09:23:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/bmj-covid-19-vaccines-for-children-hypothetical-benefits-to-adults-do-not-outweigh-risks-to-children</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16889]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[NEJM - Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines]]></title><link>https://www.omsul.pt/noticias/nejm-prevention-and-attenuation-of-covid-19-with-the-bnt162b2-and-mrna-1273-vaccines</link><description><![CDATA[ https://www.nejm.org/doi/ full/10.1056/NEJMoa2107058? query=TOC&cid=NEJM%20eToc,% 20July%2022,%202021%20B% 20DM162200_NEJM_Non_ Subscriber&bid=561013160  ]]></description><pubDate>Mon, 26 Jul 2021 09:21:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/nejm-prevention-and-attenuation-of-covid-19-with-the-bnt162b2-and-mrna-1273-vaccines</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16888]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Considerations for the use of saliva as sample material for COVID-19 testing]]></title><link>https://www.omsul.pt/noticias/ecdc-considerations-for-the-use-of-saliva-as-sample-material-for-covid-19-testing</link><description><![CDATA[ https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-use-saliva-sample-material-testing.pdf     ]]></description><pubDate>Wed, 19 May 2021 09:11:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-considerations-for-the-use-of-saliva-as-sample-material-for-covid-19-testing</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16444]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings]]></title><link>https://www.omsul.pt/noticias/ecdc-considerations-on-the-use-of-rapid-antigen-detection-including-self-tests-for-sars-cov-2-in-occupational-settings</link><description><![CDATA[ https://www.ecdc.europa.eu/sites/default/files/documents/Considerations-on-use-of-rapid-antigen-detection-tests-for-SARS-CoV-2-in-occupational-settings.pdf  ]]></description><pubDate>Wed, 19 May 2021 09:09:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-considerations-on-the-use-of-rapid-antigen-detection-including-self-tests-for-sars-cov-2-in-occupational-settings</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16443]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities]]></title><link>https://www.omsul.pt/noticias/ecdc-data-collection-on-covid-19-outbreaks-in-closed-settings-with-a-completed-vaccination-programme-long-term-care-facilities</link><description><![CDATA[ https://www.ecdc.europa.eu/sites/default/files/documents/Data-collection-on-COVID-19-outbreaks-in-closed-settings-with-a-completed-vacc-prog-LTCFs.pdf     ]]></description><pubDate>Wed, 19 May 2021 09:07:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-data-collection-on-covid-19-outbreaks-in-closed-settings-with-a-completed-vaccination-programme-long-term-care-facilities</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16442]]></dc:identifier></item><item><dc:creator><![CDATA[admin noticias]]></dc:creator><title><![CDATA[ECDC - Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA]]></title><link>https://www.omsul.pt/noticias/ecdc-overview-of-the-implementation-of-covid-19-vaccination-strategies-and-deployment-plans-in-the-eueea</link><description><![CDATA[ https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-overview-vaccination-strategies-deployment-plans-6-may-2021.pdf       ]]></description><pubDate>Wed, 19 May 2021 09:05:00 GMT</pubDate><guid>https://www.omsul.pt/noticias/ecdc-overview-of-the-implementation-of-covid-19-vaccination-strategies-and-deployment-plans-in-the-eueea</guid><dc:identifier><![CDATA[6f5b7be5-c223-48d4-a860-c411924be4ce-16441]]></dc:identifier></item></channel></rss>